Access apparatus with integrated fluid connector and control valve

Information

  • Patent Grant
  • 10675056
  • Patent Number
    10,675,056
  • Date Filed
    Tuesday, August 21, 2018
    5 years ago
  • Date Issued
    Tuesday, June 9, 2020
    3 years ago
Abstract
An access apparatus includes an access housing, an access member extending from the access housing, a fluid connector mounted to the access housing and a control valve mounted to the fluid connector. The control valve is positionable relative to the fluid connector between a first position corresponding to a desufflation operative state permitting rapid desufflation of the underlying body cavity, a second position corresponding to an insufflation operative state permitting insufflation fluid flow into the access member and into the underlying body cavity, and a third position corresponding to a closed operative state.
Description
BACKGROUND
1. Technical Field

The present disclosure relates to an access apparatus and, more particularly, relates to an access apparatus including an integrated fluid connector and valve for controlling flow of insufflation fluids during a laparoscopic procedure.


2. Description of Related Art

In laparoscopic procedures, clinicians perform surgery in the interior of the abdomen through one or more narrow tubes or cannulas inserted through small entrance openings or incisions in the skin. In certain instances, an insufflation port associated with one cannula provides a pressurized gas, e.g., CO2, into the abdominal cavity after the cannula is inserted into the entrance opening and secured to a patient, thus creating or maintaining a pneumoperitoneum. The gas provides positive pressure raising the inner abdominal wall from internal organs, thereby providing the clinician with an operating space in which a surgical procedure is performed. By creating the operating space, the clinician avoids contact with the organs while the instruments are manipulated within the cannulas.


A conventional cannula typically includes a luer connector and stop cock valve to control flow of insufflation fluids. The cannula also may incorporate a seal system having an object seal for establishing a seal about a surgical object, e.g., a surgical instrument, introduced through the cannula, and a zero-closure valve for preventing release of the pressurized gas through the cannula in the absence of the surgical object. In some of the larger diameter cannulas, the seal system may be detachable relative to the cannula, which assists in release of the insufflation gases from the abdomen subsequent to performance of the procedure.


SUMMARY

Accordingly, the present disclosure is directed to improvements in controlling entry and exit of insufflation fluids through an access apparatus such as a cannula, particularly, a cannula of relatively small diameter, e.g., 5 millimeters (mm) or less and devoid of a removable seal system. In one embodiment, an access apparatus includes an access housing, an access member extending from the access housing, a fluid connector mounted to the access housing and a control valve. The access housing and the access member define a central longitudinal axis and a longitudinal opening for passage of a surgical object. The fluid connector includes a valve chamber segment and a coupler segment depending radially outwardly relative to the valve chamber segment. The fluid connector defines a fluid passage extending through at least the valve chamber segment and the coupler segment. The valve chamber segment defines a chamber exit port in fluid communication with the fluid passage. The coupler segment is configured for coupling to an insufflation fluid source. The control valve includes a valve stem at least partially positioned within the valve chamber segment. The valve stem includes a valve channel extending through the valve stem and a valve intake port in fluid communication with the valve channel. The control valve is selectively positionable between a first position corresponding to a desufflation operative state where the valve intake port is in fluid communication with the access member and the valve channel is in fluid communication with the chamber exit port of the fluid connector to thereby permit exit of the insufflation fluids relative to the access member, a second position corresponding to an insufflation operative state where the valve channel is in fluid communication with the fluid passage of the fluid connector to permit passage of insufflation fluids from the insufflation fluid source to the access member, and a third position corresponding to a closed operative state where the valve stem intersects the fluid passage to prevent egress of insufflation fluids from the access member, and maintain, e.g., a pneumoperitoneum.


In embodiments, the control valve is configured to rotate about an axis of rotation between the first, second and third positions. In some embodiments, the axis of rotation is parallel to the central longitudinal axis of the access member.


In certain embodiments, the valve channel of the control valve is linear and is arranged about a valve channel axis. In embodiments, the valve intake port is configured to intersect the valve channel and is arranged about a valve intake port axis. In some embodiments, the valve stem includes a closed side opposing the valve intake port along the valve intake port axis. In embodiments, the closed side of the valve stem is positioned radial outward of the chamber exit port of the fluid connector when in the first position of the control valve and intersects the flow passage of the fluid connector. In embodiments, the closed side of the valve stem is configured to close the chamber exit port of the valve chamber segment of the fluid connector when in the second position of the control valve. In some embodiments, the closed side of the valve stem is positioned radial inward of the chamber exit port when in the third position of the control valve and intersects the flow passage of the fluid connector.


In embodiments, the control valve includes a valve lever connected to the valve stem, and configured for manual manipulation and being selectively movable to move the control valve between the first, second and third positions.


In some embodiments, the fluid connector and the access housing are monolithically formed.


In certain embodiments, a closure element is mounted relative to the access housing. The closure element is configured to open upon introduction of the surgical object therethrough and close in the absence of the surgical object. In embodiments, the fluid passage of the fluid connector is in fluid communication with the longitudinal opening of the access housing and the access member distal of the closure element.


In one embodiment, an access apparatus includes an access housing, an access member extending from the access housing, a fluid connector mounted to the access housing and being configured for coupling to an insufflation fluid source, and a control valve at least partially positioned within the fluid connector. The access housing and the access member define a central longitudinal axis and have a longitudinal opening for passage of a surgical object. The fluid connector defines a fluid passage extending therethrough, and has an exit port in a side wall portion thereof in fluid communication with the fluid passage. The control valve defines a valve channel therethrough and a valve intake port in fluid communication with the valve channel. The control valve is selectively positionable between a first position corresponding to a desufflation operative state where the valve intake port is aligned with the fluid passage of the fluid connector and the flow channel is aligned with the exit port of the fluid connector to permit insufflation fluids to flow from the access member through the valve intake port for discharge through the valve channel and the exit port, a second position corresponding to an insufflation operative state where the valve channel is aligned with the fluid passage of the fluid connector to permit passage of insufflation fluids from the insufflation fluid source through the fluid passage to the access member, and a third position corresponding to a closed operative state where the control valve intersects the flow passage of the fluid connector to prevent egress of insufflation fluids from the access member.


In embodiments, the fluid connector and the access housing are monolithically formed. In some embodiments, the control valve is configured to rotate about an axis of rotation between the first, second and third positions whereby the axis of rotation is parallel to the central longitudinal axis of the access member.


The integrated fluid connector and control valve permits functioning of the apparatus between three operative states, namely, a desufflation, an insufflation and a closed operative state of operation. The fluid connector is integrally formed with the access housing and requires only one opening in its sidewall. The control valve in combination with the fluid connector permits rapid desufflation even in the absence of a removable seal system.


Other advantages of the present disclosure will be appreciated from the following description.





BRIEF DESCRIPTION OF THE DRAWING(S)

Embodiments of the present disclosure will be appreciated by reference to the accompanying drawings wherein:



FIG. 1 is a perspective view of the surgical access apparatus in accordance with the present disclosure illustrating the access housing, the integrated fluid connector with the control valve mounted to the access housing, and the access member extending from the access housing;



FIG. 2 is an exploded perspective view of the access apparatus;



FIG. 3 is a first perspective view of the control valve of the access apparatus;



FIG. 4 is a second perspective view in partial cross-section of the control valve of the access apparatus;



FIG. 5 is a cross-sectional view taken along the lines 5-5 of FIG. 1 illustrating a first position of the control valve corresponding to a desufflation operative state of the access apparatus;



FIG. 6 is a cross-sectional view similar to the view of FIG. 5 illustrating a second position of the control valve corresponding to an insufflation operative state of the access apparatus; and



FIG. 7 is a cross-sectional view similar to the view of FIG. 5 illustrating a third position of the control valve corresponding to a closed operative state of the access apparatus.





DETAILED DESCRIPTION

Particular embodiments of the present disclosure are described hereinbelow with reference to the accompanying drawings; however, it is to be understood that the disclosed embodiments are merely examples of the disclosure and may be embodied in various forms. Well-known functions or constructions are not described in detail to avoid obscuring the present disclosure in unnecessary detail. Therefore, specific structural and functional details disclosed herein are not to be interpreted as limiting, but merely as a basis for the claims and as a representative basis for teaching one skilled in the art to employ the present disclosure in virtually any appropriately detailed structure.


The present disclosure has application in a variety of surgical access devices adapted for permitting percutaneous access to a target site. These access devices include, but are not limited to, trocars and/or cannulas, catheters, hand access devices, etc. The present disclosure is contemplated for use in various surgical procedures including, e.g., endoscopic, arthroscopic, thoracic, etc., but has particular application in a laparoscopic procedure performed in the abdominal cavity.


In the following description, as is traditional, the term “proximal” will refer to the portion of the instrument closest to the clinician while the term “distal” refers to the portion of the instrument most remote from the clinician.


Referring now to FIGS. 1-2, the access apparatus of the present disclosure is illustrated. The access apparatus 10 may be any member suitable for the intended purpose of accessing a body cavity and typically defines a passageway permitting introduction of instruments or the clinician's hand. The access apparatus 10 is particularly adapted for use in laparoscopic surgery where the abdominal or peritoneal cavity is insufflated with a suitable fluid or gas, e.g., CO2, to raise the cavity wall from the internal organs therein. The access apparatus 10 is typically used with an obturator assembly (not shown) which may be blunt, a non-bladed, or a sharp pointed instrument positionable within the passageway of the access apparatus 10. The obturator assembly is utilized to penetrate the abdominal wall to introduce the access apparatus 10 through the abdominal wall, and then subsequently is removed from the access apparatus 10 to permit introduction of the surgical instrumentation utilized to perform the procedure through the passageway.


The access apparatus 10 includes an access housing 12 and an access member 14 coupled to the access housing 12. The access housing 12 and the access member 14 collectively define a longitudinal axis “k”, and have a longitudinal opening 16 therethrough (cut-away portions of FIGS. 1-2). The access member 14 may be cylindrical along at least a portion of its length and defines proximal end segment 18 and distal end segment 20. The access number 14 may be a cannula dimensioned for introduction within the abdominal cavity “c”, and may include a port opening 22 in its outer wall 14a in communication with the longitudinal opening 16 and adjacent the distal end segment 20 for passage or release of insufflation fluids. In the alternative, the access member 14 may include a separate tube or channel for passage of the insufflation fluids. The access member 14, in the form of a cannula, may range from 3 mm to 15 mm. In embodiments, the access member 14 has a diameter of 5 mm or less.


The access housing 12 includes a housing segment 24, a closure element 26 disposed within the housing segment 24 and a cover 28. The housing segment 24 and the access member 14 may be monolithically formed as a single unit, or may be separate components secured to each other through conventional means. The housing segment 24 defines a semi-hemispherical or elliptical shape which tapers radially inwardly in the distal direction relative to the longitudinal axis “k”. The closure element 26 is a zero closure valve configured to open upon passage of the surgical object therethrough, and close in the absence of the surgical object and/or in response to pressure provided by the underlying insufflation fluids. The closure element 26 may be a duckbill valve defining a slit 26a which provides a passageway through the closure element 26. Other zero closure valves are also contemplated. The access housing 12 also may include an object seal (not shown) configured to establish a sealing relation about a surgical object or instrument introduced therethrough. Suitable object seals include septum seals, single slit seals, double slit seals or the like.


The cover 28 is secured to the housing segment 24 through conventional means to enclose the closure element 26 and the interior of the access apparatus 10. The cover 28 includes a central opening 30 which leads to the longitudinal opening 16. The cover 28 may include diametrically opposed openings 32 for receiving sutures (not shown) for securing the access apparatus 10 relative to the surgical site.


With continued reference to FIGS. 1-2, the access housing 12 further includes a fluid connector 34 depending radially outwardly from the outer surface of the housing segment 24. The fluid connector 34 is integral with the housing segment 24, and, in one embodiment, is monolithically formed with the housing segment 24. In the alternative, the fluid connector 34 may be a separate component secured to the housing segment 24 through a mechanical coupling, adhesive, etc. The fluid connector 34 includes a valve chamber segment 36 and a coupler segment 38 depending radially outwardly relative to the valve chamber segment 36. The valve chamber segment 36 is arranged around a chamber axis “m” (FIG. 2) which, in one embodiment, is in general parallel relation with the central longitudinal axis “k”. The valve chamber segment 36 defines an internal chamber 40 having a generally cylindrical configuration, and a single chamber exit port 42 extending through a side wall portion 36a thereof and in fluid communication with the internal chamber 40. The coupler segment 38 defines a central flow bore 44 therethrough and has an external male thread 46 (e.g., a luer coupling) for coupling to tubing of an insufflation system or source of pressurized fluids.


Referring now to FIGS. 3-4, in conjunction with FIG. 2, the access apparatus 10 includes a flow control valve 48 positionable relative to the valve chamber segment 36 of the fluid connector 34. The control valve 48 includes a valve stem 50 and a valve lever 52 coupled to the valve stem 50. The valve lever 52 is configured for engagement by the clinician to move, e.g., rotate, the control valve 48 relative to the valve chamber segment 36. The valve stem 50 is generally cylindrical in cross-section and is received within the correspondingly dimensioned internal chamber 40 of the valve chamber segment 36. The valve stem 50 includes a linear valve channel 54 arranged about a valve channel axis “b” and extending completely through opposed sides of the valve stem 50 and a valve intake port 56 on one side of the valve stem 50 and in communication with the valve channel 54. (FIG. 4) The valve intake port 56 is arranged about a valve intake port axis “e”. The valve stem 50 is closed on the side opposing the valve intake port 56 (e.g., along the valve intake port axis “e”) thereby defining a closed side 58 of the valve stem 50 diametrically opposing the valve intake port 56. In one embodiment, the valve intake port 56 is oriented at a 90° interval relative to the valve channel 54 such that the valve intake port axis “e” of the valve intake port 56 is orthogonal to the valve channel axis “b” of the valve channel 54. Other orientations are also envisioned. The valve intake port 56 defines a smaller diameter than the diameter of the valve channel 54. The valve stem 50 further includes a mounting rib 60 adjacent its distal end which defines a mounting recess 62. The mounting rib 60 and/or the mounting recess 62 interact with corresponding structure (not shown) within the valve chamber segment 36 of the fluid connector 34 to secure the control valve 48 within the valve chamber segment 36.


The valve stem 50 can be cylindrical in shape with a valve channel that is linear and passes through the valve stem from a first side to a second side, opposite the first side. The intake port 56 is orthogonal to the valve channel and opposite the closed side 58, which is formed by a wall of the valve stem.



FIG. 5 illustrates, in cross-section, the assembled access apparatus 10. In FIG. 5, the flow passage “p” extending through the fluid connector 34 is also depicted, and is inclusive of the flow bore 44 of the coupler segment 38, the internal chamber 40 of the valve chamber segment 36 and the intermediate flow bore 64 extending between the valve chamber segment 36 and the housing segment 24 of the access housing 12. The flow passage “p” permits fluid communication between the insufflation fluid source, schematically identified as reference numeral 100, and the interior of the housing segment 24 distal of the closure element 26. The flow passage “p” is generally arranged around flow axis “s” which, in one embodiment, is orthogonal to the central longitudinal axis “k”. Other arrangements are also envisioned.



FIG. 5 also illustrates a first position of the control valve 48 corresponding to the desufflation operative state of the access apparatus 10. In the first position, the valve intake port 56 of the valve stem 50 is in alignment with the intermediate flow bore 64 of the fluid connector 34 thereby establishing fluid communication with the access member 14, and the valve channel 54 is in alignment with the chamber exit port 42 of the valve chamber segment 36. The closed side 58 of the valve stem 50 is in alignment with, and intersects, the flow bore 44 of the coupler segment 38 thereby closing the fluid passage “p” to the insufflation fluid source 100. The closed side 58 of the valve stem 50 is disposed radial outward of the chamber exit port 42. Thus, in the first position, the insufflation fluids “f” may be conveyed from the access member 14 and the housing segment 24 into the fluid connector 34 and passed through the valve intake port 56 and the valve channel 54 of the valve stem 50, to rapidly exit the chamber exit port 42 of the valve chamber segment 36.



FIG. 6 illustrates a second position of the control valve 48 corresponding to the insufflation operative state of the access apparatus 10. In the second position, the closed side 58 of the valve stem 50 intersects, blocks or covers the chamber exit port 42 of the valve chamber segment 36 while the valve channel 54 of the valve stem 50 is in alignment with the flow bore 44 of the coupler segment 38 thereby completely opening the flow passage “p” through the fluid connector 34. Thus, in the second position, the insufflation fluids “f” will pass from the insufflation fluid source 100 through the fluid connector 34 and into the housing segment 24 and/or access member 14 distal of the closure element 26 within the access housing 12.



FIG. 7 illustrates a third position of the control valve 48 corresponding to the closed operative state of the access apparatus 10. In the third position, the closed side 58 of the valve stem 50 is disposed radial inward of the chamber exit port 42, and is arranged to intersect or block the intermediate flow bore 64 of the fluid connector 34 thereby closing the fluid passage “p” of the fluid connector 34 relative to the access member 14, e.g. preventing egress of insufflation fluids “f” from the access member 14. In the third state, the pneumoperitoneum is maintained without passage of insufflation fluids between the insufflation fluid source 100 and the access member 14. The insufflation fluid source 100 also may be deactivated through, e.g., closing a valve associated with the insufflation fluid source 100 or turning the source to an off-mode of operation.


The use of the access apparatus 10 will now be discussed. The access apparatus 10 is introduced through the abdominal wall to access the underlying abdominal cavity. In accordance with one methodology, an obturator (not shown) is positioned within the access apparatus 10 and advanced through the abdominal wall, e.g., through a previously created incision in the abdominal wall or through an opening created by the obturator, to position at least the distal end segment 20 of the access member 14 within the abdominal cavity “c” as depicted in FIG. 1. Prior to accessing the abdominal cavity “c”, the abdominal cavity “c” may be at least partially or fully expanded with insufflation fluids, CO2, introduced via an insufflation needle to establish a pneumoperitoneum. A surgical object, e.g., a laparoscopic surgical instrument such as a grasper, scissor, electrosurgical device, stapler, etc. may be advanced through the access apparatus 10 and into the underlying surgical site to perform a surgical task. If, during the procedure, insufflation fluids are required to establish or maintain the pneumoperitoneum, the control valve 48 may be oriented to the position of FIG. 6 corresponding to the insufflation operative state thereby permitting passage of insufflation fluids from the insufflation fluid source 100 through the fluid connector 34 and into the access member 14 for delivery within the abdominal cavity “c”. When the desired state of pneumoperitoneum is achieved, the control valve 48 may be manipulated to the position of FIG. 7 corresponding to the closed operative state which blocks egress of the insufflation fluids through the flow passage “p” of the fluid connector 34 and through the control valve 48. Upon completion of the surgery or when it is determined that rapid desufflation of the abdominal cavity is required, the control valve 48 is maneuvered to the first position depicted in FIG. 5 corresponding to the desufflation operative state, which aligns the valve intake port 56 of the valve stem 50 with the intermediate flow bore 64 of the fluid connector and aligns the valve channel 54 with the chamber exit port 42 of the valve chamber segment 36. Thus, in the first position, the insufflation fluids “f” may pass through the access member 14 and the access housing 12 into the fluid connector 34 through the valve intake port 56 and the valve channel 54 and rapidly exit the chamber exit port 42 of the valve chamber segment 36.


Thus, the integrated fluid connector 34 and control valve 48 of the present disclosure provides the ability of quick desufflation without requiring removal of a detachable seal system. Only one exit hole, chamber exit port 42, is required in the side wall of the fluid connector 34 and, in combination with the respective configurations of the valve channel 54 and the valve intake port 56 of the valve stem 50, permits ready transition between the three operative states of the access apparatus 10.


The above description and the drawings are provided for the purpose of describing embodiments of the present disclosure and are not intended to limit the scope of the disclosure in any way. It will be apparent to those skilled in the art that various modifications and variations can be made without departing from the spirit or scope of the disclosure. Thus, it is intended that the present disclosure cover the modifications and variations of this disclosure provided they come within the scope of the appended claims and their equivalents.

Claims
  • 1. An access apparatus, comprising: an access housing;an access member extending from the access housing, the access housing and the access member defining a central longitudinal axis and having a longitudinal opening for passage of a surgical object;a fluid connector mounted to the access housing, the fluid connector including a valve chamber segment and a coupler segment depending radially outwardly relative to the valve chamber segment and the longitudinal axis, the fluid connector defining a fluid passage extending at least through the valve chamber segment and the coupler segment, the valve chamber segment defining a chamber exit port in fluid communication with the fluid passage, the coupler segment configured for coupling to an insufflation fluid source; anda control valve including a valve stem at least partially positioned within the valve chamber segment, the valve stem including a valve channel extending through the valve stem and a valve intake port in fluid communication with the valve channel, the control valve selectively positionable between a first position corresponding to a desufflation operative state where the valve intake port is in fluid communication with the access member and the valve channel is in fluid communication with the chamber exit port of the fluid connector to thereby permit exit of the insufflation fluids relative to the access member, a second position corresponding to an insufflation operative state where the valve channel is in fluid communication with the fluid passage of the fluid connector and with the insufflation fluid source to permit passage of insufflation fluids from the insufflation fluid source to the access member, and a third position corresponding to a closed operative state where the valve stem intersects the fluid passage to prevent egress of insufflation fluids from the access member, wherein the control valve is configured to rotate about an axis of rotation between the first, second, and third positions, the axis of rotation being parallel to the central longitudinal axis of the access member.
  • 2. The access apparatus of claim 1 wherein the valve channel of the control valve is linear and is arranged about a valve channel axis.
  • 3. The access apparatus of claim 2 wherein the valve intake port is configured to intersect the valve channel and is arranged about a valve intake port axis.
  • 4. The access apparatus of claim 3 wherein the valve stem includes a closed side opposing the valve intake port along the valve intake port axis.
  • 5. The access apparatus of claim 4 wherein the closed side of the valve stem is positioned radial outward of the chamber exit port of the fluid connector when in the first position of the control valve and intersects the flow passage of the fluid connector.
  • 6. The access apparatus of claim 5 wherein the closed side of the valve stem is configured to close the chamber exit port of the valve chamber segment of the fluid connector when in the second position of the control valve.
  • 7. The access apparatus of claim 6 wherein the closed side of the valve stem is positioned radial inward of the chamber exit port when in the third position of the control valve and intersects the flow passage of the fluid connector.
  • 8. The access apparatus of claim 1 wherein the control valve includes a valve lever connected to the valve stem, the valve lever configured for manual manipulation and selectively movable to move the control valve between the first, second and third positions.
  • 9. The access apparatus of claim 1 wherein the fluid connector and the access housing are monolithically formed.
  • 10. The access apparatus of claim 1 including a closure element mounted relative to the access housing, the closure element configured to open upon introduction of the surgical object therethrough and close in the absence of the surgical object.
  • 11. The access apparatus according to claim 10 wherein the fluid passage of the fluid connector is in fluid communication with the longitudinal opening of the access housing and the access member distal of the closure element.
  • 12. An access apparatus, comprising: an access housing;an access member extending from the access housing, the access housing and the access member defining a central longitudinal axis and having a longitudinal opening for passage of a surgical object;a fluid connector mounted to the access housing and being configured for coupling to an insufflation fluid source, the fluid connector defining a fluid passage extending therethrough, the fluid connector defining a single exit port in a side wall portion thereof in fluid communication with the fluid passage; anda control valve at least partially positioned within the fluid connector, the control valve defining a valve channel therethrough and a valve intake port in fluid communication with the valve channel, the control valve selectively positionable between: a first position corresponding to a desufflation operative state where the valve intake port is aligned with the fluid passage of the fluid connector and the flow channel is aligned with the exit port of the fluid connector to permit insufflation fluids to flow from the access member through the valve intake port for discharge through the valve channel and the exit port;a second position corresponding to an insufflation operative state where the valve channel is aligned with the fluid passage of the fluid connector to permit passage of insufflation fluids from the insufflation fluid source through the fluid passage to the access member; anda third position corresponding to a closed operative state where the control valve intersects the flow passage of the fluid connector to prevent egress of insufflation fluids from the access member,wherein the control valve is configured to rotate about an axis of rotation between the first, second, and third positions, the axis of rotation being parallel to the central longitudinal axis of the access member.
  • 13. The access apparatus of claim 12 wherein the fluid connector and the access housing are monolithically formed.
CROSS-REFERENCE TO RELATED APPLICATIONS

This application claims the benefit of and priority to U.S. Provisional Patent Application Ser. No. 62/555,231 filed Sep. 7, 2017, the entire disclosure of which is incorporated by reference herein.

US Referenced Citations (470)
Number Name Date Kind
3402710 Paleschuck Sep 1968 A
3495586 Regenbogen Feb 1970 A
4016884 Kwan-Gett Apr 1977 A
4112932 Chiulli Sep 1978 A
4183357 Bentley et al. Jan 1980 A
4356826 Kubota Nov 1982 A
4402683 Kopman Sep 1983 A
4653476 Bonnet Mar 1987 A
4737148 Blake Apr 1988 A
4863430 Klyce et al. Sep 1989 A
4863438 Gauderer et al. Sep 1989 A
4984564 Yuen Jan 1991 A
5002557 Hasson Mar 1991 A
5073169 Raiken Dec 1991 A
5082005 Kaldany Jan 1992 A
5122122 Allgood Jun 1992 A
5159921 Hoover Nov 1992 A
5176697 Hasson et al. Jan 1993 A
5183471 Wilk Feb 1993 A
5192301 Kamiya et al. Mar 1993 A
5209741 Spaeth May 1993 A
5209754 Ahluwalia May 1993 A
5217466 Hasson Jun 1993 A
5242409 Buelna Sep 1993 A
5242415 Kantrowitz et al. Sep 1993 A
5257973 Villasuso Nov 1993 A
5257975 Foshee Nov 1993 A
5269772 Wilk Dec 1993 A
5290249 Foster et al. Mar 1994 A
5312391 Wilk May 1994 A
5312417 Wilk May 1994 A
5314417 Stephens et al. May 1994 A
5318516 Cosmescu Jun 1994 A
5330486 Wilk Jul 1994 A
5334143 Carroll Aug 1994 A
5336169 Divilio et al. Aug 1994 A
5336203 Goldhardt et al. Aug 1994 A
5337937 Remiszewski et al. Aug 1994 A
5345927 Bonutti Sep 1994 A
5360417 Gravener et al. Nov 1994 A
5366478 Brinkerhoff et al. Nov 1994 A
5375588 Yoon Dec 1994 A
5378588 Tsuchiya Jan 1995 A
5391156 Hildwein et al. Feb 1995 A
5394863 Sanford et al. Mar 1995 A
5395367 Wilk Mar 1995 A
5437683 Neumann et al. Aug 1995 A
5445615 Yoon Aug 1995 A
5451222 De Maagd et al. Sep 1995 A
5460170 Hammerslag Oct 1995 A
5464409 Mohajer Nov 1995 A
5480410 Cuschieri et al. Jan 1996 A
5490843 Hildwein et al. Feb 1996 A
5507758 Thomason et al. Apr 1996 A
5511564 Wilk Apr 1996 A
5514133 Golub et al. May 1996 A
5514153 Bonutti May 1996 A
5520698 Koh May 1996 A
5522791 Leyva Jun 1996 A
5524644 Crook Jun 1996 A
5540648 Yoon Jul 1996 A
5545150 Danks et al. Aug 1996 A
5545179 Williamson, IV Aug 1996 A
5556385 Andersen Sep 1996 A
5569159 Anderson et al. Oct 1996 A
5577993 Zhu et al. Nov 1996 A
5601581 Fogarty et al. Feb 1997 A
5624399 Ackerman Apr 1997 A
5634911 Hermann et al. Jun 1997 A
5634937 Mollenauer et al. Jun 1997 A
5643285 Rowden et al. Jul 1997 A
5649550 Crook Jul 1997 A
5651771 Tangherlini et al. Jul 1997 A
5653705 de la Torre et al. Aug 1997 A
5656013 Yoon Aug 1997 A
5672168 de la Torre et al. Sep 1997 A
5683378 Christy Nov 1997 A
5685857 Negus et al. Nov 1997 A
5697946 Hopper et al. Dec 1997 A
5709675 Williams Jan 1998 A
5713858 Heruth et al. Feb 1998 A
5713869 Morejon Feb 1998 A
5722962 Garcia Mar 1998 A
5728103 Picha et al. Mar 1998 A
5730748 Fogarty et al. Mar 1998 A
5735791 Alexander, Jr. et al. Apr 1998 A
5741298 MacLeod Apr 1998 A
5752970 Yoon May 1998 A
5782817 Franzel et al. Jul 1998 A
5795290 Bridges Aug 1998 A
5803921 Bonadio Sep 1998 A
5810712 Dunn Sep 1998 A
5813409 Leahy et al. Sep 1998 A
5830191 Hildwein et al. Nov 1998 A
5836871 Wallace et al. Nov 1998 A
5836913 Orth et al. Nov 1998 A
5840077 Rowden et al. Nov 1998 A
5842971 Yoon Dec 1998 A
5848992 Hart et al. Dec 1998 A
5853417 Fogarty et al. Dec 1998 A
5857461 Levitsky et al. Jan 1999 A
5865812 Correia Feb 1999 A
5865817 Moenning et al. Feb 1999 A
5871474 Hermann et al. Feb 1999 A
5876413 Fogarty et al. Mar 1999 A
5894843 Benetti et al. Apr 1999 A
5899208 Bonadio May 1999 A
5899913 Fogarty et al. May 1999 A
5904703 Gilson May 1999 A
5906577 Beane et al. May 1999 A
5914415 Tago Jun 1999 A
5916198 Dillow Jun 1999 A
5941898 Moenning et al. Aug 1999 A
5951588 Moenning Sep 1999 A
5957913 de la Torre et al. Sep 1999 A
5964781 Mollenauer et al. Oct 1999 A
5976174 Ruiz Nov 1999 A
5997515 de la Torre et al. Dec 1999 A
6017355 Hessel et al. Jan 2000 A
6018094 Fox Jan 2000 A
6024736 de la Torre et al. Feb 2000 A
6030402 Thompson et al. Feb 2000 A
6033426 Kaji Mar 2000 A
6033428 Sardella Mar 2000 A
6036711 Mozdzierz et al. Mar 2000 A
6042573 Lucey Mar 2000 A
6048309 Flom et al. Apr 2000 A
6059816 Moenning May 2000 A
6068639 Fogarty et al. May 2000 A
6077288 Shimomura et al. Jun 2000 A
6086603 Termin et al. Jul 2000 A
6099506 Macoviak et al. Aug 2000 A
6110154 Shimomura et al. Aug 2000 A
6142936 Beane et al. Nov 2000 A
6156006 Brosens et al. Dec 2000 A
6162196 Hart et al. Dec 2000 A
6171282 Ragsdale Jan 2001 B1
6197002 Peterson Mar 2001 B1
6217555 Hart et al. Apr 2001 B1
6228063 Aboul-Hosn May 2001 B1
6234958 Snoke May 2001 B1
6238373 de la Torre et al. May 2001 B1
6241768 Agarwal et al. Jun 2001 B1
6251119 Addis Jun 2001 B1
6254534 Butler et al. Jul 2001 B1
6264604 Kieturakis et al. Jul 2001 B1
6276661 Laird Aug 2001 B1
6293952 Brosens et al. Sep 2001 B1
6315770 de la Torre et al. Nov 2001 B1
6319246 de la Torre et al. Nov 2001 B1
6328720 McNally et al. Dec 2001 B1
6329637 Hembree et al. Dec 2001 B1
6371968 Kogasaka et al. Apr 2002 B1
6382211 Crook May 2002 B1
6423036 Van Huizen Jul 2002 B1
6440061 Wenner et al. Aug 2002 B1
6440063 Beane et al. Aug 2002 B1
6443957 Addis Sep 2002 B1
6447489 Peterson Sep 2002 B1
6450983 Rambo Sep 2002 B1
6454783 Piskun Sep 2002 B1
6464686 O'Hara et al. Oct 2002 B1
6468292 Mollenauer et al. Oct 2002 B1
6485410 Loy Nov 2002 B1
6488620 Segermark et al. Dec 2002 B1
6488692 Spence et al. Dec 2002 B1
6524283 Hopper et al. Feb 2003 B1
6527787 Fogarty et al. Mar 2003 B1
6544210 Trudel et al. Apr 2003 B1
6551270 Bimbo et al. Apr 2003 B1
6558371 Dorn May 2003 B2
6562022 Hoste et al. May 2003 B2
6572631 McCartney Jun 2003 B1
6578577 Bonadio et al. Jun 2003 B2
6582364 Butler et al. Jun 2003 B2
6589167 Shimomura et al. Jul 2003 B1
6589316 Schultz et al. Jul 2003 B1
6592543 Wortrich et al. Jul 2003 B1
6613952 Rambo Sep 2003 B2
6623426 Bonadio et al. Sep 2003 B2
6669674 Macoviak et al. Dec 2003 B1
6676639 Ternstrom Jan 2004 B1
6684405 Lezdey Feb 2004 B2
6706050 Giannadakis Mar 2004 B1
6716201 Blanco Apr 2004 B2
6723044 Pulford et al. Apr 2004 B2
6723088 Gaskill, III et al. Apr 2004 B2
6725080 Melkent et al. Apr 2004 B2
6800084 Davison et al. Oct 2004 B2
6811546 Callas et al. Nov 2004 B1
6814078 Crook Nov 2004 B2
6830578 O'Heeron et al. Dec 2004 B2
6837893 Miller Jan 2005 B2
6840946 Fogarty et al. Jan 2005 B2
6840951 de la Torre et al. Jan 2005 B2
6846287 Bonadio et al. Jan 2005 B2
6863674 Kasahara et al. Mar 2005 B2
6878110 Yang et al. Apr 2005 B2
6884253 McFarlane Apr 2005 B1
6890295 Michels et al. May 2005 B2
6913609 Yencho et al. Jul 2005 B2
6916310 Sommerich Jul 2005 B2
6916331 Mollenauer et al. Jul 2005 B2
6929637 Gonzalez et al. Aug 2005 B2
6939296 Ewers et al. Sep 2005 B2
6942633 Odland Sep 2005 B2
6945932 Caldwell et al. Sep 2005 B1
6958037 Ewers et al. Oct 2005 B2
6972026 Caldwell et al. Dec 2005 B1
6986752 McGuckin, Jr. et al. Jan 2006 B2
6991602 Nakazawa et al. Jan 2006 B2
6997909 Goldberg Feb 2006 B2
7001397 Davison et al. Feb 2006 B2
7008377 Beane et al. Mar 2006 B2
7011645 McGuckin, Jr. et al. Mar 2006 B2
7014628 Bousquet Mar 2006 B2
7033319 Pulford et al. Apr 2006 B2
7052454 Taylor May 2006 B2
7056321 Pagliuca et al. Jun 2006 B2
7077852 Fogarty et al. Jul 2006 B2
7081089 Bonadio et al. Jul 2006 B2
7083626 Hart et al. Aug 2006 B2
7100614 Stevens et al. Sep 2006 B2
7101353 Lui et al. Sep 2006 B2
7104981 Elkins et al. Sep 2006 B2
7153261 Wenchell Dec 2006 B2
7160309 Voss Jan 2007 B2
7163510 Kahle et al. Jan 2007 B2
7192436 Sing et al. Mar 2007 B2
7195590 Butler et al. Mar 2007 B2
7201725 Cragg et al. Apr 2007 B1
7214185 Rosney et al. May 2007 B1
7217277 Parihar et al. May 2007 B2
7223257 Shubayev et al. May 2007 B2
7223278 Davison et al. May 2007 B2
7235064 Hopper et al. Jun 2007 B2
7235084 Skakoon et al. Jun 2007 B2
7238154 Ewers et al. Jul 2007 B2
7258712 Schultz et al. Aug 2007 B2
7276075 Callas et al. Oct 2007 B1
7294103 Bertolero et al. Nov 2007 B2
7300399 Bonadio et al. Nov 2007 B2
7316699 McFarlane Jan 2008 B2
7331940 Sommerich Feb 2008 B2
7344547 Piskun Mar 2008 B2
7377898 Ewers et al. May 2008 B2
7390322 McGuckin, Jr. et al. Jun 2008 B2
7393322 Wenchell Jul 2008 B2
7412977 Fields et al. Aug 2008 B2
7440661 Kobayashi Oct 2008 B2
7445597 Butler et al. Nov 2008 B2
7452363 Ortiz Nov 2008 B2
7473221 Ewers et al. Jan 2009 B2
7481765 Ewers et al. Jan 2009 B2
7493703 Kim et al. Feb 2009 B2
7513361 Mills, Jr. Apr 2009 B1
7513461 Reutenauer et al. Apr 2009 B2
7520876 Ressemann et al. Apr 2009 B2
7537564 Bonadio et al. May 2009 B2
7540839 Butler et al. Jun 2009 B2
7559893 Bonadio et al. Jul 2009 B2
7608082 Cuevas et al. Oct 2009 B2
7625361 Suzuki et al. Dec 2009 B2
7645232 Shluzas Jan 2010 B2
7650887 Nguyen et al. Jan 2010 B2
7704207 Albrecht et al. Apr 2010 B2
7717846 Zirps et al. May 2010 B2
7717847 Smith May 2010 B2
7721742 Kalloo et al. May 2010 B2
7727146 Albrecht et al. Jun 2010 B2
7730629 Kim Jun 2010 B2
7736306 Brustad et al. Jun 2010 B2
7753901 Piskun et al. Jul 2010 B2
7758500 Boyd et al. Jul 2010 B2
7762995 Eversull et al. Jul 2010 B2
7766824 Jensen et al. Aug 2010 B2
7787963 Geistert et al. Aug 2010 B2
7798998 Thompson et al. Sep 2010 B2
7811251 Wenchell et al. Oct 2010 B2
7815567 Albrecht et al. Oct 2010 B2
7837612 Gill et al. Nov 2010 B2
7846123 Vassiliades et al. Dec 2010 B2
7850600 Piskun Dec 2010 B1
7850667 Gresham Dec 2010 B2
7867164 Butler et al. Jan 2011 B2
7896889 Mazzocchi et al. Mar 2011 B2
7905829 Nishimura et al. Mar 2011 B2
7909760 Albrecht et al. Mar 2011 B2
7913697 Nguyen et al. Mar 2011 B2
7951076 Hart et al. May 2011 B2
7955257 Frasier et al. Jun 2011 B2
7955313 Boismier Jun 2011 B2
7998068 Bonadio et al. Aug 2011 B2
8021296 Bonadio et al. Sep 2011 B2
8025670 Sharp et al. Sep 2011 B2
8038652 Morrison et al. Oct 2011 B2
8066673 Hart et al. Nov 2011 B2
8079986 Taylor et al. Dec 2011 B2
8092430 Richard et al. Jan 2012 B2
8105234 Ewers et al. Jan 2012 B2
8109873 Albrecht et al. Feb 2012 B2
8157786 Miller et al. Apr 2012 B2
8157817 Bonadio et al. Apr 2012 B2
8187177 Kahle et al. May 2012 B2
8187178 Bonadio et al. May 2012 B2
8241209 Shelton, IV et al. Aug 2012 B2
8262568 Albrecht et al. Sep 2012 B2
8323184 Spiegal et al. Dec 2012 B2
8335783 Milby Dec 2012 B2
8343047 Albrecht et al. Jan 2013 B2
8353824 Shelton, IV et al. Jan 2013 B2
8403889 Richard Mar 2013 B2
8480683 Fowler et al. Jul 2013 B2
8574153 Richard Nov 2013 B2
8585632 Okoniewski Nov 2013 B2
20010037053 Bonadio et al. Nov 2001 A1
20020055714 Rothschild May 2002 A1
20030014076 Mollenauer et al. Jan 2003 A1
20030093104 Bonner et al. May 2003 A1
20030187376 Rambo Oct 2003 A1
20030233115 Eversull et al. Dec 2003 A1
20030236549 Bonadio et al. Dec 2003 A1
20040059297 Racenet et al. Mar 2004 A1
20040092795 Bonadio et al. May 2004 A1
20040102804 Chin May 2004 A1
20040111052 Moenning Jun 2004 A1
20040111061 Curran Jun 2004 A1
20040138529 Wiltshire et al. Jul 2004 A1
20040204734 Wagner et al. Oct 2004 A1
20040267096 Caldwell et al. Dec 2004 A1
20050020884 Hart et al. Jan 2005 A1
20050070935 Ortiz Mar 2005 A1
20050096695 Olich May 2005 A1
20050119525 Takemoto Jun 2005 A1
20050137459 Chin et al. Jun 2005 A1
20050148823 Vaugh et al. Jul 2005 A1
20050192483 Bonadio et al. Sep 2005 A1
20050203346 Bonadio et al. Sep 2005 A1
20050209608 O'Heeron Sep 2005 A1
20050245876 Khosravi et al. Nov 2005 A1
20050251092 Howell et al. Nov 2005 A1
20050277946 Greenhalgh Dec 2005 A1
20060047185 Shener et al. Mar 2006 A1
20060071432 Staudner Apr 2006 A1
20060129165 Edoga et al. Jun 2006 A1
20060149137 Pingleton et al. Jul 2006 A1
20060149306 Hart et al. Jul 2006 A1
20060161049 Beane et al. Jul 2006 A1
20060161050 Butler et al. Jul 2006 A1
20060212063 Wilk Sep 2006 A1
20060224161 Bhattacharyya Oct 2006 A1
20060241651 Wilk Oct 2006 A1
20060247498 Bonadio et al. Nov 2006 A1
20060247499 Butler et al. Nov 2006 A1
20060247500 Voegele et al. Nov 2006 A1
20060247516 Hess et al. Nov 2006 A1
20060247586 Voegele et al. Nov 2006 A1
20060247673 Voegele et al. Nov 2006 A1
20060247678 Weisenburgh et al. Nov 2006 A1
20060270911 Voegele et al. Nov 2006 A1
20070093695 Bonadio et al. Apr 2007 A1
20070118175 Butler et al. May 2007 A1
20070151566 Kahle et al. Jul 2007 A1
20070203398 Bonadio et al. Aug 2007 A1
20070208312 Norton et al. Sep 2007 A1
20070225650 Hart et al. Sep 2007 A1
20070270654 Pignato et al. Nov 2007 A1
20070270882 Hjelle et al. Nov 2007 A1
20080009826 Miller et al. Jan 2008 A1
20080021360 Fihe et al. Jan 2008 A1
20080027476 Piskun Jan 2008 A1
20080048011 Weller Feb 2008 A1
20080091143 Taylor et al. Apr 2008 A1
20080097162 Bonadio et al. Apr 2008 A1
20080097332 Greenhalgh et al. Apr 2008 A1
20080119868 Sharp et al. May 2008 A1
20080161826 Guiraudon Jul 2008 A1
20080188868 Weitzner et al. Aug 2008 A1
20080194973 Imam Aug 2008 A1
20080200767 Ewers et al. Aug 2008 A1
20080255519 Piskun et al. Oct 2008 A1
20080319261 Lucini et al. Dec 2008 A1
20090012477 Norton et al. Jan 2009 A1
20090036738 Cuschieri et al. Feb 2009 A1
20090036745 Bonadio et al. Feb 2009 A1
20090093752 Richard et al. Apr 2009 A1
20090093850 Richard Apr 2009 A1
20090105635 Bettuchi et al. Apr 2009 A1
20090131751 Spivey et al. May 2009 A1
20090137879 Ewers et al. May 2009 A1
20090182279 Wenchell et al. Jul 2009 A1
20090182288 Spenciner Jul 2009 A1
20090187079 Albrecht et al. Jul 2009 A1
20090204067 Abu-Halawa Aug 2009 A1
20090221968 Morrison et al. Sep 2009 A1
20090227843 Smith et al. Sep 2009 A1
20090326330 Bonadio et al. Dec 2009 A1
20090326332 Carter Dec 2009 A1
20100063452 Edelman et al. Mar 2010 A1
20100100043 Racenet Apr 2010 A1
20100113886 Piskun et al. May 2010 A1
20100228094 Ortiz et al. Sep 2010 A1
20100240960 Richard Sep 2010 A1
20100249516 Shelton, IV et al. Sep 2010 A1
20100249523 Spiegal et al. Sep 2010 A1
20100249524 Ransden et al. Sep 2010 A1
20100262080 Shelton, IV et al. Oct 2010 A1
20100280326 Hess et al. Nov 2010 A1
20100286484 Stellon et al. Nov 2010 A1
20100286506 Ransden et al. Nov 2010 A1
20100298646 Stellon et al. Nov 2010 A1
20100312063 Hess et al. Dec 2010 A1
20110009704 Marczyk et al. Jan 2011 A1
20110021877 Fortier et al. Jan 2011 A1
20110028891 Okoniewski Feb 2011 A1
20110034778 Kleyman Feb 2011 A1
20110054257 Stopek Mar 2011 A1
20110054258 O'Keefe et al. Mar 2011 A1
20110054260 Albrecht et al. Mar 2011 A1
20110082341 Kleyman et al. Apr 2011 A1
20110082343 Okoniewski Apr 2011 A1
20110082346 Stopek Apr 2011 A1
20110118553 Stopek May 2011 A1
20110124968 Kleyman May 2011 A1
20110124969 Stopek May 2011 A1
20110124970 Kleyman May 2011 A1
20110125186 Fowler et al. May 2011 A1
20110166423 Farascioni et al. Jul 2011 A1
20110251463 Kleyman Oct 2011 A1
20110251464 Kleyman Oct 2011 A1
20110251465 Kleyman Oct 2011 A1
20110251466 Kleyman et al. Oct 2011 A1
20110313250 Kleyman Dec 2011 A1
20120059640 Roy et al. Mar 2012 A1
20120130177 Davis May 2012 A1
20120130181 Davis May 2012 A1
20120130182 Rodrigues, Jr. et al. May 2012 A1
20120130183 Barnes May 2012 A1
20120130184 Richard May 2012 A1
20120130185 Pribanic May 2012 A1
20120130186 Stopek et al. May 2012 A1
20120130187 Okoniewski May 2012 A1
20120130188 Okoniewski May 2012 A1
20120130190 Kasvikis May 2012 A1
20120130191 Pribanic May 2012 A1
20120149987 Richard et al. Jun 2012 A1
20120157777 Okoniewski Jun 2012 A1
20120157779 Fischvogt Jun 2012 A1
20120157780 Okoniewski et al. Jun 2012 A1
20120157781 Kleyman Jun 2012 A1
20120157782 Alfieri Jun 2012 A1
20120157783 Okoniewski et al. Jun 2012 A1
20120157784 Kleyman et al. Jun 2012 A1
20120157785 Kleyman Jun 2012 A1
20120157786 Pribanic Jun 2012 A1
20120190931 Stopek Jul 2012 A1
20120190932 Okoniewski Jul 2012 A1
20120190933 Kleyman Jul 2012 A1
20120209077 Racenet Aug 2012 A1
20120209078 Pribanic et al. Aug 2012 A1
20120245427 Kleyman Sep 2012 A1
20120245429 Smith Sep 2012 A1
20120245430 Kleyman et al. Sep 2012 A1
20120283520 Kleyman Nov 2012 A1
20130225930 Smith Aug 2013 A1
20130225931 Cruz et al. Aug 2013 A1
20130245373 Okoniewski Sep 2013 A1
20130274559 Fowler et al. Oct 2013 A1
20130310651 Alfieri Nov 2013 A1
20140018632 Kleyman Jan 2014 A1
Foreign Referenced Citations (75)
Number Date Country
2702419 Nov 2010 CA
0226026 Jun 1987 EP
0538060 Apr 1993 EP
0577400 Jan 1994 EP
0630660 Dec 1994 EP
0807416 Nov 1997 EP
0950376 Oct 1999 EP
1188415 Mar 2002 EP
1312318 May 2003 EP
1774918 Apr 2007 EP
1932485 Jun 2008 EP
2044889 Apr 2009 EP
2044897 Apr 2009 EP
2080494 Jul 2009 EP
2095781 Sep 2009 EP
2098182 Sep 2009 EP
2138117 Dec 2009 EP
2138118 Dec 2009 EP
2181657 May 2010 EP
2226025 Sep 2010 EP
2229900 Sep 2010 EP
2238924 Oct 2010 EP
2238925 Oct 2010 EP
2238926 Oct 2010 EP
2238933 Oct 2010 EP
2248478 Nov 2010 EP
2248482 Nov 2010 EP
2253283 Nov 2010 EP
2272450 Jan 2011 EP
2277464 Jan 2011 EP
2289438 Mar 2011 EP
2292165 Mar 2011 EP
2343019 Jul 2011 EP
2469083 Apr 2009 GB
8401512 Apr 1984 WO
9314801 Aug 1993 WO
9404067 Mar 1994 WO
9610963 Apr 1996 WO
9636283 Nov 1996 WO
9733520 Sep 1997 WO
9742889 Nov 1997 WO
9916368 Apr 1999 WO
9922804 May 1999 WO
9929250 Jun 1999 WO
0032116 Jun 2000 WO
0032120 Jun 2000 WO
0054675 Sep 2000 WO
0108581 Feb 2001 WO
0149363 Jul 2001 WO
0207611 Jan 2002 WO
03034908 May 2003 WO
03071926 Sep 2003 WO
03077726 Sep 2003 WO
2004043275 May 2004 WO
2004054456 Jul 2004 WO
2004075741 Sep 2004 WO
2004075930 Sep 2004 WO
2005058409 Jun 2005 WO
2006019723 Feb 2006 WO
2006100658 Sep 2006 WO
2006110733 Oct 2006 WO
2007018458 Feb 2007 WO
2007095703 Aug 2007 WO
2007143200 Dec 2007 WO
2008015566 Feb 2008 WO
2008042005 Apr 2008 WO
2008077080 Jun 2008 WO
2008093313 Aug 2008 WO
2008103151 Aug 2008 WO
2008121294 Oct 2008 WO
2008147644 Dec 2008 WO
2009036343 Mar 2009 WO
2010000047 Jan 2010 WO
2010141409 Dec 2010 WO
2010141673 Dec 2010 WO
Non-Patent Literature Citations (1)
Entry
Extended European Search Report issued in European Application No. 18192877.1 dated Dec. 14, 2018, 9 pages.
Related Publications (1)
Number Date Country
20190069925 A1 Mar 2019 US
Provisional Applications (1)
Number Date Country
62555231 Sep 2017 US